Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Understanding Pharmaceutical Consulting Services: What To Expect

Sep 25, 2025

Introduction to Pharmaceutical Consulting

Pharmaceutical consulting services play a crucial role in the healthcare industry, providing expert guidance and strategic solutions to pharmaceutical companies. These services help navigate the complexities of drug development, regulatory compliance, and market entry. Understanding what to expect from pharmaceutical consulting can be immensely beneficial for businesses looking to enhance their operations and achieve success in this competitive field.

pharmaceutical consulting

The Scope of Pharmaceutical Consulting Services

Pharmaceutical consulting encompasses a wide range of services tailored to meet the unique needs of pharmaceutical companies. These services often include assistance with drug development processes, regulatory affairs, quality assurance, and market strategy formulation. Consultants bring specialized knowledge and experience to the table, helping companies streamline operations and reduce time-to-market for new drugs.

Consulting firms often employ professionals with diverse backgrounds, including scientists, regulatory experts, and business strategists. This multidisciplinary approach ensures that all facets of a pharmaceutical project are addressed comprehensively.

Regulatory Compliance and Quality Assurance

One of the primary areas where pharmaceutical consultants provide invaluable support is in regulatory compliance. Navigating the complex landscape of regulations is critical for any pharmaceutical company aiming to bring a new product to market. Consultants assist in preparing and submitting documentation required by regulatory bodies such as the FDA or EMA, ensuring that compliance standards are met at every stage.

regulatory compliance

Quality assurance is another vital aspect where consultants contribute significantly. They help establish robust quality management systems that ensure the safety and efficacy of pharmaceutical products. By conducting audits and evaluations, consultants can identify potential risks and recommend corrective actions to improve product quality.

Market Strategy and Commercialization

Beyond development and compliance, pharmaceutical consulting services also focus on market strategy and commercialization. Consultants work with companies to devise effective marketing strategies that maximize product potential in target markets. This includes analyzing market trends, identifying key competitors, and developing pricing strategies that align with business goals.

Furthermore, consultants assist in building partnerships and alliances that can enhance distribution networks and expand market reach. Their insights into consumer behavior and market dynamics can provide companies with a competitive edge.

market strategy

Benefits of Engaging Pharmaceutical Consultants

The benefits of engaging pharmaceutical consultants are numerous. By leveraging external expertise, companies can improve operational efficiencies, reduce costs, and accelerate time-to-market for new products. Consultants provide an objective perspective that helps identify opportunities for improvement and innovation.

Additionally, their experience in dealing with regulatory authorities can prevent costly delays and ensure smoother interactions during the approval process. This proactive approach minimizes risks and enhances the likelihood of successful product launches.

Choosing the Right Consulting Partner

Selecting the right pharmaceutical consulting partner is crucial for achieving desired outcomes. Companies should look for consultants with a proven track record in their specific area of interest. Evaluating past projects, client testimonials, and case studies can provide insights into a consultant's capabilities.

It's also essential to choose a consulting firm that aligns with your company's culture and values. Effective communication and collaboration are key to ensuring a successful partnership that drives growth and innovation.

consulting partnership

In conclusion, pharmaceutical consulting services offer comprehensive support across various domains essential for the success of pharmaceutical companies. By understanding what to expect from these services, businesses can make informed decisions that positively impact their growth trajectory in the competitive pharmaceutical landscape.